Navigation Links
University researchers to develop coatings that kill superbugs

Researchers at the University of Bath are to be part of a 3 million Europe-wide research collaboration to pioneer research into safer, more effective anti-bacterial plastics and coatings that can be used in items such as food packaging, medical devices to wound dressings, and nappies.

The Bath team has developed a range of new compounds which have been shown to be highly effective against common hospital bacterial infections such as MRSA and are safer than existing anti-bacterials based on silver nanoparticles.

They will develop these compounds so they can be cheaply and efficiently incorporated into a wide range of materials from medical devices, wound dressings, food packaging and even nappies.

Led by Dr Toby Jenkins at the University of Bath, the research team comprises chemists Dr Andrew Johnson and Dr Gareth Price, and biologist Dr Nick Waterfield as well as colleagues in Barcelona, Exeter, St. Gallen (Switzerland), Mainz and Cologne (both Germany).

From the total grant, Bath will receive just less than three quarters of a million Euros, which will fund equipment and a team of three PhD students and a Research Fellow.

So-called "superbug" bacteria such as MRSA are dangerous because they are resistant to most conventional antibiotics, a problem that is getting worse each year.

To try and understand this problem, the researchers will also be studying which genes allow bacteria to become resistant.

Dr Jenkins said: "In simple terms, we want to know what is special about that one bacterium in a million that is resistant to an antimicrobial polymer. Which genes are switched on or off and which proteins are produced to help the bacterium survive?

"From this knowledge we can stay one step ahead of evolution in the fight against pathogenic bacteria and infections such as MRSA and Pseudomonas aeruginosa."

Early work by the University of Bath team has made new compounds containing zinc, copper and silver which have been effective against common hospital bacteria but are non-toxic to human cell growth.


Contact: Vicky Just
University of Bath

Related biology news :

1. K-State researchers work with university in Ghana to create biofuels from native tree seeds
2. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
3. IADR Wilmer Souder Award presented to University of Colorado professor
4. Troutlodge, University of Miami sign aquaculture agreement
5. Ben-Gurion University engineers develop technique to help combat nuclear proliferation
6. Undesirable evolution can be reversed in fish, Stony Brook University scientists show
7. Ben-Gurion University of the Negev researchers develop new reversible, green window technology
8. Queens University Belfast improves Malaysian public health
9. If youre aggressive, your dog will be too, says veterinary study at University of Pennsylvania
10. Famous fossil Lucy scanned at the University of Texas at Austin
11. Concordia University leads academic team for national Cellulosic Biofuels Network
Post Your Comments:
Related Image:
University researchers to develop coatings that kill superbugs
(Date:10/29/2015)... Oct. 29, 2015 Daon, a global leader ... has released a new version of its IdentityX ... North America have already installed IdentityX ... includes a FIDO UAF certified server component ... to activate FIDO features. These customers include some of ...
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
(Date:10/26/2015)... -- Delta ID Inc., a company focused on bringing secure ... announced its ActiveIRIS® technology powers the iris recognition feature ... NTT DOCOMO, INC in Japan . ... include iris recognition technology, after a very successful introduction ... 2015, world,s first smartphone to have this capability. ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica ... on AngelList early in their initial angel funding process. Now, they are paying ... looking to make early stage investments in the microbiome space. In this, ...
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: